Table 1.
Group | Time after Kidney Transplantation | Creatinine (in mg/dL) Med (Q1–Q2) |
eGFR (in mL/min/1.73) Med (Q1–Q2) |
Concentration of TFF3 (in ng/mL) | |||
---|---|---|---|---|---|---|---|
ELISA | Luminex | ||||||
Serum Med (Q1–Q2) |
Urine Med (Q1–Q2) |
Serum Med (Q1–Q2) |
Urine Med (Q1–Q2) |
||||
control | 0.78 (0.65–0.93) |
94 (92–112) |
7.84 (6.11–8.17) |
89.26 (79.72–90.78) |
3.18 (2.10–3.86) |
31.95 (23.88–37.78) |
|
patients after kidney transplantation | One to two days | 4.05 (2.58–5.94) |
13 (9–21) |
63.65 (31.51–82.58) |
210.4 (66.62–273.9) |
9.79 (8.24–21.46) |
35.39 (14.85–72.29) |
Six months | 1.44 (1.14–1.53) |
52 (43–68) |
15.73 (12.76–24.89) |
106.5 (43.38–268.1) |
3.52 (2.71–6.78) |
34.90 (16.13–76.40) |
|
One year | 1.32 (1.18–1.58) |
53 (47–63) |
16.22 (10.54–20.94) |
95.16 (54.80–290.8) |
4.87 (2.76–6.97) |
39.11 (19.64–83.27) |